Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
309 USD | -1.92% | -1.36% | -6.13% |
Apr. 22 | Bernstein Adjusts Price Target on Waters to $304 From $307 | MT |
Apr. 22 | Baird Adjusts Price Target on Waters to $319 From $315 | MT |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.54 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.13% | 18.33B | A- | ||
+7.15% | 217B | B | ||
+6.60% | 183B | B- | ||
+9.86% | 131B | B- | ||
+24.32% | 106B | A- | ||
-0.95% | 62.16B | A- | ||
+11.04% | 51.02B | B+ | ||
+4.81% | 50.89B | B+ | ||
-1.43% | 40.16B | A | ||
+24.40% | 31.44B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- WAT Stock
- Ratings Waters Corporation